Skip to main content
Premium Trial:

Request an Annual Quote

Enigma Diagnostics Licenses Roche Patents for PCR-based Dx

NEW YORK (GenomeWeb News) — Enigma Diagnostics has licensed two patents related to PCR technology from Roche Molecular Systems that will allow it to commercialize human and veterinary diagnostic tests worldwide, the company said today.
Porton Down, UK-based Enigma said that it has signed a term sheet for two patent licenses for the HybProbe real-time PCR chemistry and to commercialize HybProbe molecular diagnostics for human and animal testing. The company said these technologies complement its existing license for real-time PCR thermal cyclers from Celera Diagnostics. 
Enigma is developing a series of multiplexed point-of-care assays for infectious diseases including chlamydia, influenza, and MRSA.
Financial terms of the agreement were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more